Document Detail


Stature as a prognostic factor in cystic fibrosis survival.
MedLine Citation:
PMID:  11320950     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE/DESIGN: This study provides a longitudinal analysis of the National Cystic Fibrosis Patient Registry to determine if height-for-age percentile would be a useful predictor of survival. SUBJECTS: All patients were selected from the national registry (n = 19,000) maintained by the Cystic Fibrosis Foundation's 115 accredited Cystic Fibrosis Care Centers in the United States. Inclusion in our analysis required that subjects were born between 1980 and 1989; had a minimum of 4 records each; the subject was alive at age 7; and the subject had a recorded height measurement at age 7 to 8 (n = 2,773). STATISTICAL ANALYSIS: The Cox proportional hazards model was used to compare height-for-age with survival. We recorded whether a subject was less than the 5th National Center for Health Statistics (NCHS) percentile at age 5 and then in a separate analysis at age 7. Cohort effect was coded as "1" if they were born before 1982 and "0" otherwise. RESULTS: Stature is a significant prognostic indicator of survival. The relative hazard associated with height below the 5th NCHS percentile for age was significant for both males and females. In males at age 5 the relative hazard was 2.9, [95% confidence interval (CI) 1.23, 6.91; P < .02] and at age 7 it was 6.3 (95% CI 2.1, 18.8; P < .001). The relative hazard in females at age 5 was 4.3 (95% CI 2.4, 7.3; P < .0001) and at age 7 was 5.8 (95% CI 2.5, 13.1; P < .0001). APPLICATION: These highly significant relative hazard values strongly suggest that shorter patients are much more likely to die before taller patients. The dietetic professional should consider using height-for-age as an effective screening tool to identify patients at risk. Based on these data, short stature should not be considered benign to patients with cystic fibrosis. The CF team, clinicians, family, and patients need work together to maximize linear growth through medical and nutritional intervention.
Authors:
L T Beker; E Russek-Cohen; R J Fink
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Dietetic Association     Volume:  101     ISSN:  0002-8223     ISO Abbreviation:  J Am Diet Assoc     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-04-25     Completed Date:  2001-05-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7503061     Medline TA:  J Am Diet Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  438-42     Citation Subset:  AIM; IM    
Affiliation:
Pediatric Clinical Research Center, Children's Research Institute, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Body Height*
Child
Child Nutrition Disorders / complications*,  mortality
Child, Preschool
Cohort Effect
Cystic Fibrosis / complications,  mortality*
Female
Growth Disorders / etiology*,  mortality
Humans
Longitudinal Studies
Male
Prognosis
Proportional Hazards Models
Registries
Survival Analysis
Time Factors
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A longitudinal study of children's juice intake and growth: the juice controversy revisited.
Next Document:  Effect of timing of introduction of complementary foods on iron and zinc status of formula fed infan...